Cardiovascular disease as a long-term complication of treatment for testicular cancer

被引:398
作者
Huddart, RA
Norman, A
Shahidi, M
Horwich, A
Coward, D
Nicholls, J
Dearnaley, DP
机构
[1] Royal Marsden NHS Trust, Acad Unit Radiotherapy & Oncol, Surrey SM2 5PT, England
[2] Canc Res Inst, Dept Comp & Informat, Surrey, England
关键词
D O I
10.1200/JCO.2003.04.173
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess the risk of cardiovascular morbidity and cardiac risk factors in long-term survivors of testicular cancer according to treatment received. Patients and Methods: All resident male patients registered in the United Kingdom between 1982 and 1992 attending for follow-up were eligible for recruitment. Patients completed a current health questionnaire and underwent clinical review, along with hematologic, biochemical, and hormonal profiles. For patients not under routine review, follow-up information was sought from their general practitioner and mortality data were sought from the Office of National Statistics. Descriptive analysis was performed on all variables and comparisons were made among patients treated by orchidectomy and follow-up only, chemotherapy alone (C), radiotherapy alone (RT), and radiotherapy and chemotherapy. (C/RT). Results: Data on cardiovascular events were available on 992 patients. After a median follow-up of 10.2 years, 68 events had been reported, including 18 deaths. After adjusting for age, increased risk for cardiac events was seen after C (relative risk [RR] = 2.59; 95% confidence interval [CI], 1.15 to 5.84; P = .022), RT (RR = 2.40; 95% CI, 1.04 to 5.45; P = .036), and C/RT (RR = 2.78; 95% CI, 1.09 to 7.07; P = .032). There were no significant differences in cardiac risk factors. On multivariate analysis, age, treatment group, free thyroxine, protein, and magnesium levels were associated with cardiovascular disease. Conclusion: In long-term survivors of testicular cancer, we observed a two-fold or greater risk of developing cardiovascular disease. This was not due to increases in cardiac risk factors, which suggests a direct or indirect treatment effect. These data support the continued research into the minimization of treatment in good-prognosis testicular cancer. (C) 2003 by American Society of Clinical Oncology.
引用
收藏
页码:1513 / 1523
页数:11
相关论文
共 41 条
[1]   Endocrinological late effects after chemotherapy for testicular cancer [J].
Berger, CC ;
Bokemeyer, C ;
Schuppert, F ;
Schmoll, HJ .
BRITISH JOURNAL OF CANCER, 1996, 73 (09) :1108-1114
[2]   Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer [J].
Berger, CC ;
Bokemeyer, C ;
Schneider, M ;
Kuczyk, MA ;
Schmoll, HJ .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) :2229-2238
[3]   LONG-TERM SEQUELAE OF TREATMENT FOR TESTICULAR GERM-CELL TUMORS [J].
BISSETT, D ;
KUNKELER, L ;
ZWANENBURG, L ;
PAUL, J ;
GRAY, C ;
SWAN, IRC ;
KERR, DJ ;
KAYE, SB .
BRITISH JOURNAL OF CANCER, 1990, 62 (04) :655-659
[4]   Evaluation of long-term toxicity after chemotherapy for testicular cancer [J].
Bokemeyer, C ;
Berger, CC ;
Kuczyk, MA ;
Schmoll, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) :2923-2932
[5]   LACK OF LATE TOXICITY IN PATIENTS TREATED WITH CISPLATIN-CONTAINING COMBINATION CHEMOTHERAPY FOR METASTATIC TESTICULAR CANCER [J].
BOYER, M ;
RAGHAVAN, D ;
HARRIS, PJ ;
LIETCH, J ;
BLEASEL, A ;
WALSH, JC ;
ANDERSON, S ;
TSANG, CS .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) :21-26
[6]   CLINICAL RADIATION NEPHROPATHY [J].
CASSADY, JR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1249-1256
[7]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]   IRRADIATION-RELATED ISCHEMIC-HEART-DISEASE [J].
CORN, BW ;
TROCK, BJ ;
GOODMAN, RL .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) :741-750
[9]   Regular review - Managing testicular cancer [J].
Dearnaley, DP ;
Huddart, RA ;
Horwich, A .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7302) :1583-1588
[10]   RADIATION-INJURY IN THE HUMAN KIDNEY - A PROSPECTIVE ANALYSIS USING SPECIFIC SCINTIGRAPHIC AND BIOCHEMICAL END-POINTS [J].
DEWIT, L ;
ANNINGA, JK ;
HOEFNAGEL, CA ;
NOOIJEN, WJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (04) :977-983